Diabetic retinopathy: vascular and inflammatory disease
F Semeraro, A Cancarini, R dell'Omo… - Journal of diabetes …, 2015 - Wiley Online Library
Diabetic retinopathy (DR) is the leading cause of visual impairment in the working‐age
population of the Western world. The pathogenesis of DR is complex and several vascular …
population of the Western world. The pathogenesis of DR is complex and several vascular …
Role of cytokines and chemokines in angiogenesis in a tumor context
M Geindreau, M Bruchard, F Vegran - Cancers, 2022 - mdpi.com
Simple Summary Tumor growth in solid cancers requires adequate nutrient and oxygen
supply, provided by blood vessels created by angiogenesis. Numerous studies have …
supply, provided by blood vessels created by angiogenesis. Numerous studies have …
Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
D Unterleuthner, P Neuhold, K Schwarz, L Janker… - Angiogenesis, 2020 - Springer
WNT2 acts as a pro-angiogenic factor in placental vascularization and increases
angiogenesis in liver sinusoidal endothelial cells (ECs) and other ECs. Increased WNT2 …
angiogenesis in liver sinusoidal endothelial cells (ECs) and other ECs. Increased WNT2 …
[HTML][HTML] VEGFR1 signaling in retinal angiogenesis and microinflammation
Five vascular endothelial growth factor receptor (VEGFR) ligands (VEGF-A,-B,–C,-D, and
placental growth factor [PlGF]) constitute the VEGF family. VEGF-A binds VEGF receptors 1 …
placental growth factor [PlGF]) constitute the VEGF family. VEGF-A binds VEGF receptors 1 …
Vascular endothelial growth factors and angiogenesis in eye disease
AN Witmer, G Vrensen, CJF Van Noorden… - Progress in retinal and …, 2003 - Elsevier
The vascular endothelial growth factor (VEGF) family of growth factors controls pathological
angiogenesis and increased vascular permeability in important eye diseases such as …
angiogenesis and increased vascular permeability in important eye diseases such as …
The discovery of placenta growth factor and its biological activity
S De Falco - Experimental & molecular medicine, 2012 - nature.com
Angiogenesis is a complex biological phenomenon crucial for a correct embryonic
development and for post-natal growth. In adult life, it is a tightly regulated process confined …
development and for post-natal growth. In adult life, it is a tightly regulated process confined …
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
C Fischer, M Mazzone, B Jonckx, P Carmeliet - Nature Reviews Cancer, 2008 - nature.com
Less than 5 years ago, it was still not clear whether anti-angiogenic drugs would prove
successful in the clinic. After numerous patients with cancer or age-related macular …
successful in the clinic. After numerous patients with cancer or age-related macular …
Current and emerging therapies for corneal neovascularization
The cornea is unique because of its complete avascularity. Corneal neovascularization
(CNV) can result from a variety of etiologies including contact lens wear; corneal infections; …
(CNV) can result from a variety of etiologies including contact lens wear; corneal infections; …
Regulation of vascular growth and function in the human placenta
During the course of 9 months, the human placenta develops into a highly vascular organ.
Vasculogenesis starts during the third week post-conception. Hemangioblastic cell cords …
Vasculogenesis starts during the third week post-conception. Hemangioblastic cell cords …
Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy
P Kaufmann, TM Mayhew, DS Charnock-Jones - Placenta, 2004 - Elsevier
In this second review, we describe the main morphological events which accompany the
development of the fetoplacental vascular system throughout normal human pregnancy and …
development of the fetoplacental vascular system throughout normal human pregnancy and …